Zolwing 5 Tablet

This dual-action formulation is intended for short-term use in patients experiencing difficulty initiating or maintaining sleep. Zolwing 5 Tablet should be administered orally, typically 30 minutes before bedtime, and dosing should be individualized based on patient response and tolerability. Caution is advised in patients with a history of substance abuse, respiratory impairment, or hepatic dysfunction.

Common adverse effects may include dizziness, headache, and daytime drowsiness. Due to the risk of dependence and tolerance, prolonged use beyond recommended duration is discouraged. Patients should avoid concomitant use of alcohol or other central nervous system depressants. Zolwing 5 Tablet is contraindicated in individuals with hypersensitivity to its components and should be used under strict medical supervision to ensure safety and efficacy in the management of sleep disturbances.